Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
11.94
+0.36 (3.11%)
At close: Apr 2, 2026, 4:00 PM EDT
12.18
+0.24 (2.01%)
After-hours: Apr 2, 2026, 7:21 PM EDT
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $1.53 billion as of April 2, 2026. Its market cap has increased by 132.84% in one year.
Market Cap
1.53B
Enterprise Value
1.35B
1-Year Change
132.84%
Ranking
Category
Stock Price
$11.94
Market Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $1.53B, an increase of 1,703.84%. That is a compound annual growth rate of 51.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 1.53B | -4.51% |
| Dec 31, 2025 | 1.61B | 336.04% |
| Dec 31, 2024 | 368.19M | 330.28% |
| Dec 29, 2023 | 85.57M | -26.01% |
| Dec 30, 2022 | 115.65M | 472.04% |
| Dec 31, 2021 | 20.22M | -54.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rapport Therapeutics | 1.61B |
| Harmony Biosciences Holdings | 1.60B |
| Nurix Therapeutics | 1.60B |
| Oculis Holding AG | 1.58B |
| MBX Biosciences | 1.57B |
| Immunocore Holdings | 1.56B |
| Intellia Therapeutics | 1.55B |
| Nanobiotix | 1.53B |